Alzheimer’s disease community from our Head of Research and Development, Alfred Sandrock, M.D., Ph.D.
The Pharma Data
JULY 22, 2021
We believe that this will be further established as we collect more data from the ongoing EMBARK study and the post-marketing confirmatory trial. That was exemplified at its best with the COVID-19 vaccine development. ADUHELM is the first Alzheimer’s treatment approved since 2003.
Let's personalize your content